Patient feedback of dosen taken (visual/acoustic)

Lactose carrier (taste feedback)

Dose counter

Dose counter measuring inhalations actually taken

Accurate & consistent dose delivery

FPF air flow rate independence

> 6yrs Achievable IFR (asthmatic child, severe asthma COPD)

++ Device resistance

Minimum FR controlled to achieve adequate lung deposition?


Dose metering: blister pack (maximum)

(200) Reservoir (maximum)

Advance warning of last dose

Protection from ambient humidity

Device lock.out


200 Max. number of doses


How to use Novolizer

The Novolizer®…

  • Is a dry powder inhaler with multiple feedback mechanism to reassure the patient that the inhalation was carried out correctly.
  • Is equipped with a dosage stop system releasing the following dose only after the previous dose has been inhaled correctly.
  • Has a dose counter which moves after successful inhalation and provides so compliance measurement.
  • Is avoiding underdosing
  • Has a low-to-medium intrinsic resistance. An inspiratory flow rate of at least 35 l/min is necessary to overcome the trigger threshold. However it has been demonstrated that even children aged 4 to 5 years achieved higher peak inspiratory flow rates than required (in average 60 l/min).
  • During an inhalation manoeuvre about 90% of the metered dose is delivered at the mouthpiece with only little variability.

Compared with other devices the Novolizer® has unique features not present in any other DPI.

Drugs approved for use with the Novolizer® include budesonide (Novopulmon®, Budecort®), formoterol (Formatris®, Formotop®), and salbutamol (Ventilastin®, Salbu®).

This section contains a list of things you should do (DOs) and things you shouldn’t do (DON’Ts) when using the Novolizer. This list only covers items known from practice to be the most important and most likely to be forgotten or performed incorrectly by patients; this information is in addition to the prescribing and other information provided with the Novolizer.